Literature DB >> 19386719

Effective downregulation of HLA-A*2 and HLA-B*57 by primary human immunodeficiency virus type 1 isolates cultured from elite suppressors.

Eric Nou1, Yan Zhou, Damaris D Nou, Joel N Blankson.   

Abstract

Elite controllers or suppressors (ES) are human immunodeficiency virus type 1 (HIV-1)-infected patients who control viral replication to <50 copies/ml without antiretroviral therapy. Downregulation of HLA class I molecules is an important mechanism used by HIV-1 to evade the immune system. In this study, we showed that primary isolates from ES are as effective as isolates obtained from patients with progressive HIV-1 disease at downregulating HLA-A*2 and HLA-B*57 molecules on primary CD4(+) T cells. Thus, a diminished ability of viral isolates from ES to evade HIV-specific immune responses probably does not contribute to the control of viral replication in these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386719      PMCID: PMC2698562          DOI: 10.1128/JVI.00306-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1.

Authors:  Michael Schindler; Jan Münch; Olaf Kutsch; Hui Li; Mario L Santiago; Frederic Bibollet-Ruche; Michaela C Müller-Trutwin; Francis J Novembre; Martine Peeters; Valerie Courgnaud; Elizabeth Bailes; Pierre Roques; Donald L Sodora; Guido Silvestri; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

2.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

Authors:  S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.

Authors:  Toshiyuki Miura; Mark A Brockman; Chanson J Brumme; Zabrina L Brumme; Jonathan M Carlson; Florencia Pereyra; Alicja Trocha; Marylyn M Addo; Brian L Block; Alissa C Rothchild; Brett M Baker; Theresa Flynn; Arne Schneidewind; Bin Li; Yaoyu E Wang; David Heckerman; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription.

Authors:  Yan Zhou; Lin Shen; Hung-Chih Yang; Robert F Siliciano
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

5.  Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.

Authors:  Justin R Bailey; Karen O'Connell; Hung-Chih Yang; Yefei Han; Jie Xu; Benjamin Jilek; Thomas M Williams; Stuart C Ray; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

6.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

7.  HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.

Authors:  Toshiyuki Miura; Mark A Brockman; Zabrina L Brumme; Chanson J Brumme; Florencia Pereyra; Alicja Trocha; Brian L Block; Arne Schneidewind; Todd M Allen; David Heckerman; Bruce D Walker
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

8.  Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.

Authors:  Stephen A Migueles; Christine M Osborne; Cassandra Royce; Alex A Compton; Rohan P Joshi; Kristin A Weeks; Julia E Rood; Amy M Berkley; Jonah B Sacha; Nancy A Cogliano-Shutta; Margaret Lloyd; Gregg Roby; Richard Kwan; Mary McLaughlin; Sara Stallings; Catherine Rehm; Marie A O'Shea; JoAnn Mican; Beverly Z Packard; Akira Komoriya; Sarah Palmer; Ann P Wiegand; Frank Maldarelli; John M Coffin; John W Mellors; Claire W Hallahan; Dean A Follman; Mark Connors
Journal:  Immunity       Date:  2008-12-08       Impact factor: 31.745

9.  Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo.

Authors:  Martha J Lewis; Arumugam Balamurugan; Ayako Ohno; Stephanie Kilpatrick; Hwee L Ng; Otto O Yang
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

Review 10.  HIV-1 Nef: at the crossroads.

Authors:  John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

View more
  9 in total

1.  HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.

Authors:  Maria Salgado; Michael D Swanson; Christopher W Pohlmeyer; Robert W Buckheit; Jin Wu; Nancie M Archin; Thomas M Williams; David M Margolis; Robert F Siliciano; J Victor Garcia; Joel N Blankson
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

Review 2.  Success and failure of the cellular immune response against HIV-1.

Authors:  Stephen A Migueles; Mark Connors
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

3.  Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells.

Authors:  Richard Apps; Zhaojing Meng; Gregory Q Del Prete; Jeffrey D Lifson; Ming Zhou; Mary Carrington
Journal:  J Immunol       Date:  2015-03-09       Impact factor: 5.422

4.  Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Authors:  Rebecca T Veenhuis; Abena K Kwaa; Caroline C Garliss; Rachel Latanich; Maria Salgado; Christopher W Pohlmeyer; Christopher L Nobles; John Gregg; Eileen P Scully; Justin R Bailey; Frederic D Bushman; Joel N Blankson
Journal:  JCI Insight       Date:  2018-09-20

5.  HIV type 1-mediated downregulation of HLA-B*57/B*5801 proteins on elite suppressor CD4+ T cells.

Authors:  Maame Efua S Sampah; Christina M Ceccato; Joel N Blankson
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-04       Impact factor: 2.205

Review 6.  Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

Authors:  Joel N Blankson
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

7.  Structure of tumor necrosis factor-alpha haploblocks in European populations.

Authors:  Aimee M Merino; Kui Zhang; Richard A Kaslow; Brahim Aissani
Journal:  Immunogenetics       Date:  2013-04-12       Impact factor: 2.846

8.  Attenuation of multiple Nef functions in HIV-1 elite controllers.

Authors:  Philip Mwimanzi; Tristan J Markle; Eric Martin; Yoko Ogata; Xiaomei T Kuang; Michiyo Tokunaga; Macdonald Mahiti; Florencia Pereyra; Toshiyuki Miura; Bruce D Walker; Zabrina L Brumme; Mark A Brockman; Takamasa Ueno
Journal:  Retrovirology       Date:  2013-01-07       Impact factor: 4.602

9.  HLA-C downregulation by HIV-1 adapts to host HLA genotype.

Authors:  Nathaniel D Bachtel; Gisele Umviligihozo; Suzanne Pickering; Talia M Mota; Hua Liang; Gregory Q Del Prete; Pramita Chatterjee; Guinevere Q Lee; Rasmi Thomas; Mark A Brockman; Stuart Neil; Mary Carrington; Bosco Bwana; David R Bangsberg; Jeffrey N Martin; Esper G Kallas; Camila S Donini; Natalia B Cerqueira; Una T O'Doherty; Beatrice H Hahn; R Brad Jones; Zabrina L Brumme; Douglas F Nixon; Richard Apps
Journal:  PLoS Pathog       Date:  2018-09-04       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.